Genetic analysis of the glycoprotein 2 gene in patients with chronic pancreatitis

Pancreas

Volumn 39, Issue 3, 2010, Pages 353-358

  Masson, Emmanuelle ^a,b,c   Paliwal, Sumit ^d   Bhaskar, Seema ^d   Prakash, Soami ^d   Scotet, Virginie ^a,b,c   Reddy, D Nageshwar ^e   Le Maréchal, Cédric ^a,b,c,f   Ratan Chandak, Giriraj ^d   Chen, Jian Min ^a,b,c   Férec, Claude ^a,b,c,f  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^c Institut Federatif de Recherche IFR 148   (France)

^d CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^e ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

^f CHU MORVAN   (France)

Author keywords

Association study; Chronic pancreatitis; Glycoprotein 2; GP2; Missense mutation; Susceptibility gene

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CHRONIC PANCREATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; EXON; FAMILIAL CHRONIC PANCREATITIS; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLYCOPROTEIN 2 GENE; HAPLOTYPE; HEREDITARY CHRONIC PANCREATITIS; HUMAN; IDIOPATHIC CHRONIC PANCREATITIS; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK; SERINE PROTEINASE INHIBITOR KAZAL TYPE 1 GENE; TROPICAL CALCIFIC PANCREATITIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; MUTATION, MISSENSE; PANCREATITIS, CHRONIC; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 77950204271     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bb9620     Document Type: Article

References (31)

1. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14:141-145.
2. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000;25:213-216.
3. Rosendahl J, Witt H, Szmola R, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008;40:78-82.
4. Masson E, Chen JM, Scotet V, et al. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 2008;123:83-91.
5. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998;339: 645-652.
6. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998;339:653-658.
7. Chen JM, Férec C. Chronic pancreatitis: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2009;10:63-87. (doi:10.1146/annurev-genom-082908- 150009).
8. Hoops TC, Rindler MJ. Isolation of the cDNA encoding glycoprotein-2 (GP-2), the major zymogen granule membrane protein. Homology to uromodulin/Tamm-Horsfall protein. J Biol Chem. 1991;266: 4257-4263.
9. Freedman SD, Sakamoto K, Venu RP. GP2, the homologue to the renal cast protein uromodulin, is a major component of intraductal plugs in chronic pancreatitis. J Clin Invest. 1993;92:83-90.
10. Le Maréchal C, Masson E, Chen JM, et al. Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet. 2006; 38:1372-1374.
11. Masson E, Le Maréchal C, Chandak GR, et al. Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. Clin Gastroenterol Hepatol. 2008;6:82-88.
12. Masson E, Le Maréchal C, Delcenserie R, et al. Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. Hum Genet. 2008;123:521-529.
13. Masson E, Le Maréchal C, Chen JM, et al. Detection of a large genomic deletion in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet. 2006;14:1204-1208.
14. Masson E, Le Maréchal C, Levy P, et al. Co-inheritance of a novel deletion of the entire SPINK1 gene with a CFTR missense mutation (L997F) in a family with chronic pancreatitis. Mol Genet Metab. 2007;92:168-175.
15. Audrézet MP, Chen JM, Raguénès O, et al. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat. 2004;23:343-357.
16. Férec C, Casals T, Chuzhanova N, et al. Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur J Hum Genet. 2006;14:567-576.
17. Masson E, Le Maréchal C, Chen JM, et al. Absence of mesotrypsinogen gene (PRSS3) copy number variations in patients with chronic pancreatitis. Pancreas. 2008;37:227-228.
18. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology. 1999;117:7-10.
19. Chen JM, Raguénès O, Férec C, et al. The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis. Gastroenterology. 1999;117:1508-1509.
20. Chen JM, Mercier B, Audrézet MP, et al. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology. 2001;120:1061-1064.
21. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol. 2008;8:169-182.
22. Chandak GR, Idris MM, Reddy DN, et al. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut. 2004;53:723-728.
23. Mahurkar S, Reddy DN, Rao GV, et al. Genetic mechanisms underlying pathogenesis of tropical calcific pancreatitis. World J Gastroenterol. 2009;15:264-269.
24. Mahurkar S, Idris MM, Reddy DN, et al. Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut. 2006; 55:1270-1275.
25. Weiss FU, Behn CO, Simon P, et al. Cathepsin B gene polymorphism Val26 is not associated with idiopathic chronic pancreatitis in European patients. Gut. 2007;56:1322-1323.
26. Witt H, Sahin-Tóth M, Landt O, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38:668-673.
27. Santhosh S, Witt H, te Morsche RH, et al. A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection against chronic pancreatitis. Pancreas. 2008;36:317-320.
28. Kume K, Masamune A, Takagi Y, et al. A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders. Gut. 2009;58:820-824.
29. Sundaresan S, Chacko A, Dutta AK, et al. Divergent roles of SPINK1 and PRSS2 variants in tropical calcific pancreatitis. Pancreatology. 2008;9:145-149.
30. Mahurkar S, Bhaskar S, Reddy DN, et al. The G191R variant in PRSS2 gene does not play a role in protection against tropical calcific pancreatitis. Gut. 2009;58:881-882.
31. Chen JM, Férec C. The true culprit within the SPINK1 p.N34S-containing haplotype is still at large. Gut. 2009;58:478-480.